Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Bitcoin Slips 0.6% on the Week to US$82,046 | Crypto, Oct 16

Bitcoin closed at US$82,046 on Friday 16 October, down 0.61% on the week, while Coinbase fell 5.79% and Strategy 9.56% in a tech selloff. The post Bitcoin Slips 0.6% on the Week to US$82,046 | Crypto, Oct 16 appeared first on The Rio Times .

Bitcoin's price slipped 0.6% on the week to reach US$82,046 on October 16. The drop amounted to 0.12% for the day and 0.61% from the 9th of October. Ethereum held steady closing at US$2,440.60, virtually unchanged on the week. Crypto-linked shares, however, plummeted more significantly: Coinbase fell 5.79%, Strategy fell 9.56%, and the IBIT bitcoin fund dropped 0.94%.

Wall Street's tech stocks took the brunt of a 2.14% decline in the Nasdaq, as crypto-linked equities followed the downturn. US spot bitcoin funds witnessed about US$145 million in net outflows during the week, according to Crypto Briefing. The gap between Bitcoin's price and the shares tied to it highlighted that equity investors, rather than coin holders, bore the brunt of the sell-off.

Polymarket predicted a slight edge for Bitcoin to outperform gold in 2026 at 42.5%, with the S&P 500 favored at 69.0%.

Written by urgent.news from The Rio Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at riotimesonline.com →

More in Finance & Markets

Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Bristol-Myers trades at a significant valuation discount, but its higher leverage and patent risks contrast sharply with Johnson & Johnson's diversified stability.

  • Bristol-Myers Squibb reports $48.2 billion revenue in fiscal year 2025, down 0.2%.
  • Johnson & Johnson reports $94.2 billion revenue in fiscal year 2025, up 6%.
  • Johnson & Johnson has been a Dividend King for 64 consecutive years.

More from Saturday 17 October →